Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [697]

ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease...

Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital...

ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer ( Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital, US )

AACR 2009: Common genetic variations and predisposition to cancer

Prof Bruce Ponder - Cancer Research UK, Cambridge Institute

AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )

AACR 2009: 100 years of AACR

Dr Margaret Foti - CEO of the American Association for Cancer Research

AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )

AACR 2009: Anti-angiogenics to tackle brain and prostate tumours

Prof Gabriele Bergers - University of California, San Francisco

AACR 2009: Anti-angiogenics to tackle brain and prostate tumours ( Prof Gabriele Bergers - University of California, San Francisco )

AACR 2009: Determinants of screening colonoscopy among african-american older...

Prof Jean Ford - Dept of Epidemiology, Johns Hopkins University Bloomberg...

AACR 2009: Determinants of screening colonoscopy among african-american older adults ( Prof Jean Ford - Dept of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, USA )

AACR 2009: Genetic influences in response to EGFR for metastatic colorectal...

Frederica Di Nicolantonio - Laboratory of Molecular Genetics, Institute for...

AACR 2009: Genetic influences in response to EGFR for metastatic colorectal cancer ( Frederica Di Nicolantonio - Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Turin Medical School, Italy )

AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel...

Dr Mamta Gupta - Mayo Clinic Cancer Center, USA

AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeutic Approach for Pancreatic Cancer ( Dr Mamta Gupta - Mayo Clinic Cancer Center, USA )

Bacteria as agents to initiate potent anti-tumour activity

Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of...

Bacteria as agents to initiate potent anti-tumour activity ( Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan )

ECCO 15 - ESMO 34 Executive Scientific Programme Committee

ECCO-ESMO Roundtable discussion - Full Version

ECCO 15 - ESMO 34 Executive Scientific Programme Committee ( ECCO-ESMO Roundtable discussion - Full Version )

Flinders University, Australia

Dr. Christos Karapetis

Flinders University, Australia ( Dr. Christos Karapetis )

University Hospital Gasthuisberg

Prof. Eric Van Cutsem

University Hospital Gasthuisberg ( Prof. Eric Van Cutsem )

Results of the new Cetuximab studies in mCRC, from ASCO 2008

Professor Eric Van Cutsem

Results of the new Cetuximab studies in mCRC, from ASCO 2008 ( Professor Eric Van Cutsem )

More from ecancer